Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

Bullboard (GREY:ATBPF)

View:
Comment by MrMugsyon Jan 02, 2024 10:47pm

RE:RE:RE:RE:RE:Early warrant exercise

I wouldn't get too hung up on these warrants.  The math makes sense to me. Let's put it this way ... If you could get 100% (or a high percentage) of the warrants exercised in this 1 ...more  
Comment by baggerx99on Jan 01, 2024 11:35am

RE:RE:RE:RE:RE:Early warrant exercise

Can only assume the session with Allele Capital on Jan 18 will spark interest from warrant holders and maybe even news on the IDB  front which is expected Q1. Would there be some motivation to ...more  
Comment by matt2018on Dec 31, 2023 3:51pm

RE:RE:RE:RE:Early warrant exercise

if the holders of these warrants want to dump them after acquiring them for a buck, thats fine. The bigger issue is why the rush to get this potential $6.5M? Whats odd is back oin Dec 12th they ...more  
Comment by Duster340on Dec 30, 2023 10:14am

RE:RE:RE:Early warrant exercise

there has to be some catalyst announcement, i think it has to be the start of P2 in dans "conversation with antibe" speach on jan/18. because the regular blah blah blah speach will not get ...more  
Comment by Benedictuson Dec 29, 2023 11:46pm

RE:RE:Early warrant exercise

Right, just guessing here, but it seems likely they would want to announce the start of p2 prior to this "incentive" window opening up and then bank on that confirmation driving the sp ...more  
Post by Betteryear2on Dec 29, 2023 10:25am

Antibe Announces Early Warrant Exercise Incentive Program

December 29, 2023 07:00 AM Eastern Standard Time TORONTO--(BUSINESS WIRE)--Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical-stage company leveraging its hydrogen sulfide platform to ...more  
Comment by matt2018on Dec 29, 2023 10:21am

RE:Early warrant exercise

I dont see how any news can be released during this period of the discounted exercise of warrants period of Jan 16 to Feb 15. Looks like they would like to raise $6.5M during this period through this ...more  
Post by Duster340on Dec 29, 2023 8:27am

Early warrant exercise

i do not think this is good for the stock price. dan throws a monkey wrench into the stock price getting much traction if any ahead of jan/18th to mid febuary. When a warrant is exercised, the ...more  
Comment by MrMugsyon Dec 26, 2023 7:56pm

RE:(ATBPF) ATE on the us exchange

I'll say it like this ... The up and down movement in the price means nothing. The present price and the movements are not sending the price where it belongs ... because ... where it belongs is ...more  
Post by Duster340on Dec 26, 2023 4:18pm

(ATBPF) ATE on the us exchange

down 2.36 cents or 3.45%, was down as much as 4 cents. so i guess that means catch-up tomorrow for ATE?
Post by MrMugsyon Dec 23, 2023 2:26pm

Merry Christmas All

What a great pivot it's been. New formulation, safer product and more control.  Let's see where they take that in 2024 as we go to P2 for Acute and as they use DILIsym to plan out a ...more  
Post by Duster340on Dec 20, 2023 12:49pm

Also

most experts think a pullback in the (record high)market early in the newyear. a buying opportunity to get back in cheaper next year.
Post by Duster340on Dec 20, 2023 12:44pm

Antibe selling off

today, no surprise the stock got ahead of itself. still a long way away untill start of P2 most likely not until march, and results not untill september 2024
Post by Duster340on Dec 14, 2023 8:01am

A Conversation With Antibe Therapeutics

15 Prince Arthur Ave. Toronto, ON, Canada, M5R 1B2 TSX:ATE OTCQX:ATBPF antibethera.com  ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities